₹ 20.4
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Panjon Ltd. specializes in the production and commercialization of both conventional (allopathic) and traditional (Ayurvedic) pharmaceutical goods. Its extensive product line encompasses tablets, balms, inhalers, and cough remedies, alongside its well-known Swad and Swad Chatpati digestive candies. Established in 1964 by Nagin Bhai Kothari, the firm's main operations are directed from its headquarters in Indore, India.
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITD.
Data is available to registered users only